Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fujisawa Pharmaceutical Co. Ltd.

Division of Astellas Pharma Inc.
www.fujisawa.co.jp

Latest From Fujisawa Pharmaceutical Co. Ltd.

Appointments: BMS CCO Leaves, New Medical Heads At Astellas Americas, Epizyme, CEOs At NanoViricides, Aeglea, Waverley Pharma

Bristol-Myers Squibb's CCO Murdo Gordon has exited the company in the week of its Q2 results, while Trevi Therapeutics, Turnstone Biologics, Aeglea BioTherapeutics, Acadia Pharmaceuticals, NanoViricides and Waverley Pharmaceuticals add to their C-suite. Medical heads join Epizyme and Astellas Americas.

Appointments BioPharmaceutical

Astellas Dips Into Digital Health Via New Venture

New venture DigiTx will give Astellas a leg up in its quest to access novel digital health technologies, in a move unveiled as the Japanese firm reported continued strong growth for top product Xtandi.

Commercial Deals

Deals of the Week: Options Abound As Forest Keeps Its Eyes On A Prize-Winner

Reflecting a long trend, three of this past week’s deals include option arrangements, including one with a new twist. Also, a rare disease partnership between Shire and Atlas Venture finally leads to a deal and Takeda continues building its vaccines business.

BioPharmaceutical Deals

Drais In Third Deal With Astellas, Seeks To Expand Partnership Model

Astellas has returned for a third time to enlist the development services of Drais, out-licensing a nocturia candidate which Drais will house in a virtual development company, Tacurion. Drais’ challenge now is to expand its portfolio of single-asset companies and its roster of investors.

Deals Strategy
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register